stockrowBausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Shares outstanding
Bausch + Lomb Corporation's shares outstanding at the end of fiscal 2025 was $353.8M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $361.5M. Over the past ten years it has ranged from $350.0M (fiscal 2021) to $353.8M (fiscal 2025) — the current reading is the highest in ten years. Bausch + Lomb Corporation ranks 5th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $353.8M | 0.57% |
| FY2024 | $351.8M | 0.37% |
| FY2023 | $350.5M | 0.09% |
| FY2022 | $350.2M | 0.06% |
| FY2021 | $350.0M | 0.00% |
| FY2020 | $350.0M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $361.5M | 1.23% |
| Jun 2026 | $357.1M | 0.53% |
| Mar 2026 | $355.2M | 0.40% |
| Dec 2025 | $353.8M | (0.11%) |
| 19 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AVTR Avantor, Inc. compare | $680.9M |
| BLCO Bausch + Lomb Corporation | $361.5M |
| MMED MiniMed Group, Inc. compare | $281.0M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| ALGN Align Technology, Inc. compare | $71.0M |
| ATR AptarGroup, Inc. compare | $64.1M |
| MMSI Merit Medical Systems, Inc. compare | $60.4M |
| RGEN Repligen Corporation compare | $56.6M |
| TFX Teleflex Incorporated compare | $43.7M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement